Excitatory neurons downregulate synaptic proteins before motor onset and glia reduce neuronal support in Huntington disease mice

Background: Huntington's disease burdens protein homeostasis and affects neurons and glia differently across brain regions, but how these two main cell populations respond as the disease progresses remains unresolved. Whole-tissue proteomes mix these cell types and hide how the proteome of each changes. We therefore measured the proteome of each cell type separately at different disease stages. Methods: We metabolically labelled cell-type-specific proteomes in living R6/1 mice and wild-type littermates for 15 days at different disease stages. We examined cortical and hippocampal excitatory neurons at 1.5, 3 and 7 months, cerebellar inhibitory neurons at 3 and 7 months, and cortical, striatal and cerebellar glia at 7 months. We combined mass spectrometry with functional enrichment and competitive protein-set tests to understand the differential proteostatic response to mutant huntingtin across disease progression, brain regions and cell types. Differential abundance was tested with a peptide-centric linear mixed model (msqRob, Benjamini-Hochberg q < 0.1), and proteins whose levels varied together in cortical and hippocampal neurons were grouped into modules by weighted correlation network analysis. Results: Hippocampal excitatory neurons showed broader and more coordinated regulation than cortical neurons already before motor onset, whereas the cortical response increased with age and no cortical protein module differed between genotypes before the most severe stage. All three neuronal populations upregulated ubiquitin-proteasome system (UPS) proteins as the disease advanced. Protein folding changed, with more subunits of the chaperonin CCT/TRiC but fewer J-domain proteins and, in excitatory neurons, fewer HSP70 chaperones. At the most severe stage, glia of the three studied regions regulated mainly different proteins, but all increased UPS proteins and decreased key proteins of neuronal support, among them the main glial glutamate transporter GLT-1. Cholesterol-related proteins decreased in cortical and cerebellar glia, and respiratory-chain proteins in striatal glia. Conclusions: Synaptic proteins decreased early in cortical and hippocampal neurons and were not restored at later ages. A later and broader maintenance response coexisted with their continued and increasing downregulation. In this first cell-type-resolved view of the labelled proteome in a Huntington's disease mouse model, progression appears as a change in the coordination of cellular functions, which whole-tissue measurements would dilute.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.766120
Primary Topic
Genetic Neurodegenerative Diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Excitatory neurons downregulate synaptic proteins before motor onset and glia reduce neuronal support in Huntington disease mice

Ella Doron‐Mandel, Beatriz Alvarez‐Castelao, Kristina Desch, Miguel Díaz‐Hernández et al.
bioRxiv (Cold Spring Harbor Laboratory)
Genetic Neurodegenerative Diseases
preprint

Excitatory neurons downregulate synaptic proteins before motor onset and glia reduce neuronal support in Huntington disease mice

Ella Doron‐Mandel, Beatriz Alvarez‐Castelao, Kristina Desch, Miguel Díaz‐Hernández, Eugenio F. Fornasiero, Héctor Albert‐Gascó, Max Gubert Olivé, Patricia Rodriguez‐Rodriguez, Sicheng Luo, Marko Jovanović, Cristina Olmedo Salinas, Javier Lázaro Sánchez, Josep Muncunill, Rodrigo Alvarez Pardo
preprint en

Abstract

Background: Huntington's disease burdens protein homeostasis and affects neurons and glia differently across brain regions, but how these two main cell populations respond as the disease progresses remains unresolved. Whole-tissue proteomes mix these cell types and hide how the proteome of each changes. We therefore measured the proteome of each cell type separately at different disease stages. Methods: We metabolically labelled cell-type-specific proteomes in living R6/1 mice and wild-type littermates for 15 days at different disease stages. We examined cortical and hippocampal excitatory neurons at 1.5, 3 and 7 months, cerebellar inhibitory neurons at 3 and 7 months, and cortical, striatal and cerebellar glia at 7 months. We combined mass spectrometry with functional enrichment and competitive protein-set tests to understand the differential proteostatic response to mutant huntingtin across disease progression, brain regions and cell types. Differential abundance was tested with a peptide-centric linear mixed model (msqRob, Benjamini-Hochberg q < 0.1), and proteins whose levels varied together in cortical and hippocampal neurons were grouped into modules by weighted correlation network analysis. Results: Hippocampal excitatory neurons showed broader and more coordinated regulation than cortical neurons already before motor onset, whereas the cortical response increased with age and no cortical protein module differed between genotypes before the most severe stage. All three neuronal populations upregulated ubiquitin-proteasome system (UPS) proteins as the disease advanced. Protein folding changed, with more subunits of the chaperonin CCT/TRiC but fewer J-domain proteins and, in excitatory neurons, fewer HSP70 chaperones. At the most severe stage, glia of the three studied regions regulated mainly different proteins, but all increased UPS proteins and decreased key proteins of neuronal support, among them the main glial glutamate transporter GLT-1. Cholesterol-related proteins decreased in cortical and cerebellar glia, and respiratory-chain proteins in striatal glia. Conclusions: Synaptic proteins decreased early in cortical and hippocampal neurons and were not restored at later ages. A later and broader maintenance response coexisted with their continued and increasing downregulation. In this first cell-type-resolved view of the labelled proteome in a Huntington's disease mouse model, progression appears as a change in the coordination of cellular functions, which whole-tissue measurements would dilute.

bioRxiv (Cold Spring Harbor Laboratory)
Universitat Jaume I (ES), Universidad Complutense de Madrid (ES), Karolinska Institutet (SE), Universitätsmedizin Göttingen (DE), Health Research Institute of the Balearic Islands (ES), Max Planck Institute for Brain Research (DE), University of Göttingen (DE), Columbia University (US)
Comunidad de Madrid, Deutsche Forschungsgemeinschaft, Universidad Complutense de Madrid, Hjärnfonden, Ministerio de Ciencia e Innovación, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, National Institutes of Health
Good health and well-being
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon